Theratechnologies Inc. (TH) — Cash Flow Reinvestment Rate

Latest as of May 2025: 3.81x

Theratechnologies Inc. (TH) has a Cash Flow Reinvestment Rate of 3.81x as of May 2025, reinvesting CA$10.12 Million (capex CA$10.11 Million plus investments CA$-8.00K) from operating cash flow of CA$2.66 Million. Check Theratechnologies Inc. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

3.81x
(Capex + Investments) / Operating CF

Total Reinvested

CA$10.12 Million
Capex + Investments

Operating Cash Flow

CA$2.66 Million
CAD

Capital Expenditures

CA$10.11 Million
CAD

Theratechnologies Inc. Cash Flow Reinvestment Rate (2009–2024)

Historical reinvestment intensity for Theratechnologies Inc. across 6 annual periods. Explore TH long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Theratechnologies Inc. (2009–2024)

Year-by-year capital reinvestment analysis for Theratechnologies Inc.. For live market cap and broader valuation context, see Theratechnologies Inc. (TH) market capitalisation.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2024 1.03x CA$2.44 Million CA$2.38 Million CA$1.50 Million ▼ -87.9%
2017 8.50x CA$16.21 Million CA$1.91 Million CA$73.82K ▲ +61.3%
2016 5.27x CA$10.55 Million CA$2.00 Million CA$1.19 Million ▲ +1080.7%
2015 0.45x CA$2.36 Million CA$5.30 Million CA$31.00K ▲ +211.7%
2010 0.14x CA$407.05K CA$2.84 Million CA$407.05K ▲ +98.9%
2009 0.07x CA$384.80K CA$5.35 Million CA$384.80K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow